Journals / Türk Oftalmoloji Dergisi / 2021 / Cilt: 51 - Sayı: 2

Efficacy of Intense Pulsed Light Treatment for Moderate to Severe AcuteBlepharitis or Blepharoconjunctivitis: A Retrospective Case Series

Orta ve İleri Şiddette Akut Blefarit ya da Blefarokonjonktivit için Yoğun Atımlı Işık Tedavisi: Retrospektif Olgu Serisi

Pages
89–94
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Significant improvements in OSDI symptom scores (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We aimed to evaluate the efficacy of periocular intense pulsed light (IPL) therapy in the treatment of moderate to severe acute blepharitis or blepharoconjunctivitis.
📊
Key Findings & Data:The following findings obtained at baseline and 10 weeks after the treatment were recorded: slit-lamp examinations; symptom scores of the Compression of the Eyelid (COTE) grading system and Ocular Surface Disease Index (OSDI); ocular surface staining with Oxford grading scale (OXFORD) scores; lipid layer thickness (LLT); and non-invasive tear meniscus test (TMH), non-invasive break up time measurement (NIBUT), and meibography performed by using I.C.P.
💡
Conclusion & Impact:Results: Significant improvements in OSDI symptom scores (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: We aimed to evaluate the efficacy of periocular intense pulsed light (IPL) therapy in the treatment of moderate to severe acute blepharitis or blepharoconjunctivitis. Materials and Methods: This was a retrospective study performed in one institution. Eleven patients who received bilateral periocular IPL therapy using an IPL device (E>Eye, ESwin, Paris, France) were retrospectively evaluated. The following findings obtained at baseline and 10 weeks after the treatment were recorded: slit-lamp examinations; symptom scores of the Compression of the Eyelid (COTE) grading system and Ocular Surface Disease Index (OSDI); ocular surface staining with Oxford grading scale (OXFORD) scores; lipid layer thickness (LLT); and non-invasive tear meniscus test (TMH), non-invasive break up time measurement (NIBUT), and meibography performed by using I.C.P. Ocular Surface Analyzer (SBM System, Turin, Italy). Results: Significant improvements in OSDI symptom scores (p

Özet

Amaç: Orta ve ileri şiddette akut blefarit ya da blefarokonjonktivit tedavisinde perioküler yoğun atımlı ışık (YAI) uygulamasının etkinliğini değerlendirmek. Gereç ve Yöntem: Bu retrospektif çalışma tek bir merkezde yapılmıştır. YAI cihazı (E>Eye, ESwin, Paris, Fransa) ile bilateral perioküler YAI tedavisi alan 11 hasta retrospektif olarak değerlendirildi. Tedavi öncesi ve tedaviden 10 hafta sonra şu değerlendirmeler yapıldı: biyomikroskopik muayene, kapak kompresyon dereceleme sistemi (Compression Of The Eyelid, COTE), Oküler Yüzey Hastalık İndeksi Skoru [Ocular Surface Disease Index (OSDİ)], oküler yüzey boyama Oxford skalası (OXFORD scale), lipid tabakası kalınlığı (LTK), non-invazif gözyaşı menisküs testi [non-invasive tear meniscus test (TMH)], non-invazif gözyaşı kırılma zamanı [non-invasive break up time measurement (NIBUT)] ölçümü ve I.C.P. Oküler Yüzey Analizörü (SBM Sistemi, Turin, İtalya) ile yapılan meiobografi. Bulgular: Bilateral perioküler YAI tedavisinden 10 hafta sonra OSDİ semptom skorunda (p

🔖

Cite This Article

TOTUK, Ö. M. G., KABADAYI, K., ÖZKAPI, C., AYKAN, Ü. (2022). Efficacy of Intense Pulsed Light Treatment for Moderate to Severe AcuteBlepharitis or Blepharoconjunctivitis: A Retrospective Case Series. Türk Oftalmoloji Dergisi, Cilt: 51 - Sayı: 2, 89–94. https://ajindex.com/articles/637602

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, Foulks GN. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52:1930-1937
  2. Viswalingam M, Rauz S, Morlet N, Dart JKG. Blepharokeratoconjunctivitis in children: diagnosis and treatment. Br J Ophthalmol. 2005;89:400-403
  3. Lindsley K, Matsumura S, Hatef E, Akpek EK. Interventions for chronic blepharitis. Cochrane Database Syst Rev. 2012:CD005556
  4. Rong B, Tang Y, Liu R, Tu P, Qiao J, Song W, Yan X. Long-term effects of ıntense pulsed light combined with meibomian gland expression in the treatment of meibomian gland dysfunction. Photomed Laser Surg. 2018;36:562-567
  5. Seo KY, Kang SM, Ha DY, Chin HS, Jung JW. Long-term effects of intense pulsed light treatment on the ocular surface in patients with rosacea-associated meibomian gland dysfunction. Cont Lens Anterior Eye. 2018;41:430-435
  6. Vegunta S, Patel D, Shen JF. Combination therapy of ıntense pulsed light therapy and meibomian gland expression (IPL/MGX) can improve dry eye symptoms and meibomian gland function in patients with refractory dry eye: a retrospective analysis. Cornea. 2016;35:318-322
  7. Dell SJ. Intense pulsed light for evaporative dry eye disease. Clin Ophthalmol. 2017;11:1167-1173
  8. Küçümen RB, Utine CA, Görgün E, Yenerel NM, Ziylan S, Çiftçi F. Evaluation of tear film osmolarity in cases with chronic belpharitis. [In Turkish] Turk J Ophthalmol. 2015;45:5-8
  9. Alves M, Fonseca EC, Alves MF, Malki LT, Arruda GV, Reinach PS, Rocha EM. Dry eye disease treatment: a systematic review of published trials and a critical appraisal of therapeutic strategies. Ocul Surf. 2013;11:181-192
  10. Torkildsen GL, Cockrum P, Meier E, Hammonds WM, Silverstein B, Silverstein S. Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/ blepharoconjunctivitis. Curr Med Res Opin. 2011;27:171-178
  11. Thode AR, Latkany RA. Current and emerging therapeutic strategies for the treatment of meibomian gland dysfunction. Drugs. 2015;75:1177-1185
  12. Akova YA, Asena L. Meibomian Gland Dysfunction: Review. Turkiye Klinikleri J Ophthalmol. 2014;23:172-183
  13. Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O’Brien T, Rolando M, Tsubota K, Nichols KK. The International Workshop